Skip to main
AMN

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 29%
Sell 14%
Strong Sell 0%

Bulls say

AMN Healthcare Services is well positioned in the market due to its diverse suite of talent solutions and strong focus on healthcare workforce needs. The company's recent Q1 financial results show impressive outperformance and strong momentum, with nearly a third of its revenue coming from its largest customer, Kaiser Permanente. Despite some headwinds in certain segments, AMN has a strong growth algorithm and an expected double-digit EBITDA growth. A potential economic downturn and the loss of its largest customer could impact profitability, but we maintain a positive outlook on the stock and a $26 price target, considering its current EV/EBITDA multiple (7.7x) and estimated 2027 adjusted EBITDA of $196M.

Bears say

AMN Healthcare Services is expected to experience compressed international business revenue due to visa retrogression headwinds and a decrease in VMS revenue due to secular pressures in the healthcare staffing industry. Additionally, acquisitions announced in 2021 may not provide significant benefits and there are various risks and challenges that could impact the company's growth potential and profitability. Furthermore, with a significant amount of debt and declining revenue, the company may also struggle with paying off its debt.

AMN has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 7 analysts, AMN has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.57, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.57, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.